Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Helius Medical Technologies Inc (HSM.TO)

Helius Medical Technologies Inc (HSM.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 42,531
  • Shares Outstanding, K 2,318
  • Annual Sales, $ 661 K
  • Annual Income, $ -14,130 K
  • 60-Month Beta 1.09
  • Price/Sales 53.86
  • Price/Cash Flow N/A
  • Price/Book 4.02
Trade HSM.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -8.24
  • Most Recent Earnings -2.58 on 06/30/21
  • Next Earnings Date 08/12/21
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -2.20
  • Number of Estimates 1
  • High Estimate -2.20
  • Low Estimate -2.20
  • Prior Year -3.85
  • Growth Rate Est. (year over year) +42.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.83 +15.92%
on 08/17/21
19.68 -6.76%
on 08/10/21
-1.52 (-7.65%)
since 08/09/21
3-Month
15.83 +15.92%
on 08/17/21
21.17 -13.32%
on 06/25/21
+0.88 (+5.04%)
since 06/09/21
52-Week
14.26 +28.68%
on 01/04/21
40.00 -54.13%
on 01/05/21
-1.25 (-6.38%)
since 09/09/20

Most Recent Stories

More News
Helius Medical Technologies, Inc. Announces Voluntary De-Listing from Toronto Stock Exchange

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that it has provided written notice to the Toronto...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 14.65 (-0.27%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Announces FDA Breakthrough Device Designation for the Treatment of Dynamic Gait and Balance Deficits Following a Stroke

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that it has received Breakthrough Designation...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 14.65 (-0.27%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Reports Second Quarter 2021 Financial Results

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today reported financial results for the quarter ended June...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 14.65 (-0.27%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Helius Medical Technologies, Inc. (Nasdaq: HSDT) (TSX: HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that, effective August 10, 2021, its independent...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 14.65 (-0.27%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Launches New Website for U.S.-Based Patients and Physicians

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that the Company has launched a new website:...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 14.65 (-0.27%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. to Present at Two Upcoming Investor Conferences in July

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that management will participate in the following...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 14.65 (-0.27%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Appoints Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical Officer

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced the appointment of Antonella Favit-Van Pelt,...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 14.65 (-0.27%)
HSM.TO : 18.35 (-1.71%)
JNJ : 164.75 (-0.28%)
TEVA : 8.99 (+0.45%)
BMY : 61.31 (+0.13%)
Helius Medical Technologies, Inc. to Participate in the Annual World Congress of the Society for Brain Mapping and Therapeutics

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced it will participate in the Annual World Congress...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 14.65 (-0.27%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021

Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that second quarter of fiscal year 2021 financial...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 14.65 (-0.27%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Expands Executive Leadership Team with the Appointment of Dane C. Andreeff as President and Chief Executive Officer and Jeffrey S. Mathiesen as Chief Financial Officer

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that Dane C. Andreeff and Jeffrey S. Mathiesen...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 14.65 (-0.27%)
HSM.TO : 18.35 (-1.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 18.57
2nd Resistance Point 18.52
1st Resistance Point 18.44
Last Price 18.35
1st Support Level 18.31
2nd Support Level 18.26
3rd Support Level 18.18

See More

52-Week High 40.00
Fibonacci 61.8% 30.17
Fibonacci 50% 27.13
Fibonacci 38.2% 24.09
Last Price 18.35
52-Week Low 14.26

See More

Business Summary

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire unique and non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's first product, known as the Portable Neuromodulation...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar